Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1

Journal of Neuroimmunology

Volumn 212, Issue 1-2, 2009, Pages 125-131

  Enevold, Christian ^a   Oturai, Annette Bang ^a   Sørensen, Per Soelberg ^a   Ryder, Lars Peter ^a   Koch Henriksen, Nils ^a,b   Bendtzen, Klaus ^a  

^a Rigshospitalet   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Multiple sclerosis; Multiple sclerosis severity score; Pattern recognition receptors; Single nucleotide polymorphism; Toll like receptors

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; PATTERN RECOGNITION RECEPTOR; PROTEIN IFIH1; RECEPTOR PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENOTYPE; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; DEAD-BOX RNA HELICASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; IMMUNITY, INNATE; MALE; MICE; MIDDLE AGED; MULTIPLE SCLEROSIS; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS; TOLL-LIKE RECEPTORS;

EID: 67649853307     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.04.008     Document Type: Article

References (67)

1. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2 (2001) 675-680
2. Alonso A., Jick S.S., Olek M.J., and Hernan M.A. Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort. J. Neurol. 254 (2007) 1736-1741
3. Baranzini S.E., Wang J., Gibson R.A., Galwey N., Naegelin Y., Barkhof F., Radue E.W., Lindberg R.L., Uitdehaag B., Johnson M.R., Angelakopoulou A., Hall L., Richardson J.C., Prinjha R.K., Gass A., Geurts J.J., Kragt J., Sombekke M., Vrenken H., Qualley P., Lincoln R.R., Gomez R., Caillier S.J., George M.F., Mousavi H., Guerrero R., Okuda D.T., Cree B.A., Green A., Waubant E., Goodin D.S., Pelletier D., Matthews P.M., Hauser S.L., Kappos L., Polman C.H., and Oksenberg J.R. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum. Mol. Genet. 18 (2009) 767-778
4. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
5. Bertrams J., Kuwert E., and Liedtke U. HL-A antigens and multiple sclerosis. Tissue Antigens 2 (1972) 405-408
6. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J., and Kwak L.W. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298 (2002) 1025-1029
7. Bortolin S., Black M., Modi H., Boszko I., Kobler D., Fieldhouse D., Lopes E., Lacroix J.M., Grimwood R., Wells P., Janeczko R., and Zastawny R. Analytical validation of the tag-it high-throughput microsphere-based universal array genotyping platform: application to the multiplex detection of a panel of thrombophilia-associated single-nucleotide polymorphisms. Clin. Chem. 50 (2004) 2028-2036
8. Brand O.J., Lowe C.E., Heward J.M., Franklyn J.A., Cooper J.D., Todd J.A., and Gough S.C. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin. Endocrinol. (Oxf.) 66 (2007) 508-512
9. Carvalho A., Santos M., Maciel P., and Rodrigues F. T-1237C polymorphism of TLR9 gene is not associated with multiple sclerosis in the Portuguese population. Mult. Scler. 14 (2008) 550-552
10. Challoner P.B., Smith K.T., Parker J.D., MacLeod D.L., Coulter S.N., Rose T.M., Schultz E.R., Bennett J.L., Garber R.L., and Chang M. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7440-7444
11. Compston A. The genetic epidemiology of multiple sclerosis. Philos. Trans. R. Soc. Lond., B Biol. Sci. 354 (1999) 1623-1634
12. Compston A., and Coles A. Multiple sclerosis. Lancet 359 (2002) 1221-1231
13. Couturier, N., Gourraud, P.A., Cournu-Rebeix, I., Gout, C., Bucciarelli, F., Edan, G., Babron, M.C., Clerget-Darpoux, F., Clanet, M., Fontaine, B., Brassat, D., in press. IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients. Eur. J. Hum. Genet. (Electronic publication ahead of print). doi:10.1038/ejhg.2008.259.
14. Creagh E.M., and O'Neill L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27 (2006) 352-357
15. Derfuss T., Gurkov R., Then B.F., Goebels N., Hartmann M., Barz C., Wilske B., Autenrieth I., Wick M., Hohlfeld R., and Meinl E. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain 124 (2001) 1325-1335
16. Duquette P., Pleines J., Girard M., Charest L., Senecal-Quevillon M., and Masse C. The increased susceptibility of women to multiple sclerosis. Can. J. Neurol. Sci. 19 (1992) 466-471
17. Dyment D.A., Sadovnick A.D., and Ebers G.C. Genetics of multiple sclerosis. Hum. Mol. Genet. 6 (1997) 1693-1698
18. Ebers G.C., Sadovnick A.D., and Risch N.J. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377 (1995) 150-151
19. Gregory S.G., Schmidt S., Seth P., Oksenberg J.R., Hart J., Prokop A., Caillier S.J., Ban M., Goris A., Barcellos L.F., Lincoln R., McCauley J.L., Sawcer S.J., Compston D.A., Dubois B., Hauser S.L., Garcia-Blanco M.A., Pericak-Vance M.A., and Haines J.L. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 39 (2007) 1083-1091
20. Guo S.W., and Thompson E.A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48 (1992) 361-372
21. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., Pericak-Vance M.A., Gregory S.G., Rioux J.D., McCauley J.L., Haines J.L., Barcellos L.F., Cree B., Oksenberg J.R., and Hauser S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357 (2007) 851-862
22. Ichikawa H.T., Williams L.P., and Segal B.M. Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J. Immunol. 169 (2002) 2781-2787
23. IMSGC. The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun. 10 (2009) 11-14
24. Janeway Jr. C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54 Pt 1 (1989) 1-13
25. Jersild C., Svejgaard A., and Fog T. HL-A antigens and multiple sclerosis. Lancet 1 (1972) 1240-1241
26. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., Prestwich G.D., Mascarenhas M.M., Garg H.G., Quinn D.A., Homer R.J., Goldstein D.R., Bucala R., Lee P.J., Medzhitov R., and Noble P.W. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11 (2005) 1173-1179
27. Kerfoot S.M., Long E.M., Hickey M.J., Andonegui G., Lapointe B.M., Zanardo R.C., Bonder C., James W.G., Robbins S.M., and Kubes P. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J. Immunol. 173 (2004) 7070-7077
28. Koch-Henriksen N., and Sorensen P.S. The Danish National Project of interferon-beta treatment in relapsing-remitting multiple sclerosis. The Danish Multiple Sclerosis Group. Mult. Scler. 6 (2000) 172-175
29. Kroner A., Vogel F., Kolb-Maurer A., Kruse N., Toyka K.V., Hemmer B., Rieckmann P., and Maurer M. Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis. J. Neuroimmunol. 165 (2005) 161-165
30. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
31. Kurtzke J.F. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6 (1993) 382-427
32. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P.L., Jensen F.E., Rosenberg P.A., Volpe J.J., and Vartanian T. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 22 (2002) 2478-2486
33. Liu K., and Muse S.V. PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 21 (2005) 2128-2129
34. Liu S., Wang H., Jin Y., Podolsky R., Reddy M.V., Pedersen J., Bode B., Reed J., Steed D., Anderson S., Yang P., Muir A., Steed L., Hopkins D., Huang Y., Purohit S., Wang C.Y., Steck A.K., Montemari A., Eisenbarth G., Rewers M., and She J.X. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum. Mol. Genet. 18 (2009) 358-365
35. Lundmark F., Duvefelt K., Iacobaeus E., Kockum I., Wallstrom E., Khademi M., Oturai A., Ryder L.P., Saarela J., Harbo H.F., Celius E.G., Salter H., Olsson T., and Hillert J. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 39 (2007) 1108-1113
36. Marta M., Andersson A., Isaksson M., Kampe O., and Lobell A. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Eur. J. Immunol. 38 (2008) 565-575
37. Martinez A., Santiago J.L., Cenit M.C., de Las Heras V., de la Calle H., Fernandez-Arquero M., Arroyo R., de la Concha E.G., and Urcelay E. IFIH1-GCA-KCNH7 locus: influence on multiple sclerosis risk. Eur. J. Hum. Genet. 16 (2008) 861-864
38. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215
39. Naito S., Namerow N., Mickey M.R., and Terasaki P.I. Multiple sclerosis: association with HL-A3. Tissue Antigens 2 (1972) 1-4
40. Nejentsev S., Walker N., Riches D., Egholm M., and Todd J.A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324 (2009) 387-389
41. Nguyen L.T., Ramanathan M., Weinstock-Guttman B., Baier M., Brownscheidle C., and Jacobs L.D. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients. J. Neurol. Sci. 209 (2003) 93-99
42. O'Doherty C., Kantarci O., and Vandenbroeck K. IL7RA polymorphisms and susceptibility to multiple sclerosis. N. Engl. J. Med. 358 (2008) 753-754
43. Orton S.M., Herrera B.M., Yee I.M., Valdar W., Ramagopalan S.V., Sadovnick A.D., and Ebers G.C. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 5 (2006) 932-936
44. Panitch H.S. Influence of infection on exacerbations of multiple sclerosis. Ann. Neurol. 36 (1994) S25-S28 Suppl
45. Park J.S., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J.Y., Strassheim D., Sohn J.W., Yamada S., Maruyama I., Banerjee A., Ishizaka A., and Abraham E. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol., Cell Physiol. 290 (2006) C917-C924
46. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., and Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13 (1983) 227-231
47. Qin H., Wilson C.A., Lee S.J., Zhao X., and Benveniste E.N. LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia. Blood 106 (2005) 3114-3122
48. Racke M.K., Hu W., and Lovett-Racke A.E. PTX cruiser: driving autoimmunity via TLR4. Trends Immunol. 26 (2005) 289-291
49. Reindl M., Lutterotti A., Ingram J., Schanda K., Gassner C., Deisenhammer F., Berger T., and Lorenz E. Mutations in the gene for toll-like receptor 4 and multiple sclerosis. Tissue Antigens 61 (2003) 85-88
50. Revesz T., Kidd D., Thompson A.J., Barnard R.O., and McDonald W.I. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 117 Pt 4 (1994) 759-765
51. Rocken M., Urban J.F., and Shevach E.M. Infection breaks T-cell tolerance. Nature 359 (1992) 79-82
52. Roxburgh R.H., Seaman S.R., Masterman T., Hensiek A.E., Sawcer S.J., Vukusic S., Achiti I., Confavreux C., Coustans M., le P.E., Edan G., McDonnell G.V., Hawkins S., Trojano M., Liguori M., Cocco E., Marrosu M.G., Tesser F., Leone M.A., Weber A., Zipp F., Miterski B., Epplen J.T., Oturai A., Sorensen P.S., Celius E.G., Lara N.T., Montalban X., Villoslada P., Silva A.M., Marta M., Leite I., Dubois B., Rubio J., Butzkueven H., Kilpatrick T., Mycko M.P., Selmaj K.W., Rio M.E., Sa M., Salemi G., Savettieri G., Hillert J., and Compston D.A. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64 (2005) 1144-1151
53. Rozen S., and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132 (2000) 365-386
54. Sawcer S., Maranian M., Hensiek A., Roxburgh R., Gray J., and Compston A. Crohn's associated NOD2 gene variants are not involved in determining susceptibility to multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 74 (2003) 1157
55. Segal B.M., Chang J.T., and Shevach E.M. CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo. J. Immunol. 164 (2000) 5683-5688
56. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., Andreoni L., Trivedi P., Salvetti M., Faggioni A., and Aloisi F. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 204 (2007) 2899-2912
57. Sherry S.T., Ward M.H., Kholodov M., Baker J., Phan L., Smigielski E.M., and Sirotkin K. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29 (2001) 308-311
58. Sibley W.A., Bamford C.R., and Clark K. Clinical viral infections and multiple sclerosis. Lancet 1 (1985) 1313-1315
59. Smyth D.J., Cooper J.D., Bailey R., Field S., Burren O., Smink L.J., Guja C., Ionescu-Tirgoviste C., Widmer B., Dunger D.B., Savage D.A., Walker N.M., Clayton D.G., and Todd J.A. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 38 (2006) 617-619
60. Sriram S., Stratton C.W., Yao S., Tharp A., Ding L., Bannan J.D., and Mitchell W.M. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann. Neurol. 46 (1999) 6-14
61. Sutherland A., Davies J., Owen C.J., Vaikkakara S., Walker C., Cheetham T.D., James R.A., Perros P., Donaldson P.T., Cordell H.J., Quinton R., and Pearce S.H. Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. J. Clin. Endocrinol. Metab. 92 (2007) 3338-3341
62. Taylor J.D., Briley D., Nguyen Q., Long K., Iannone M.A., Li M.S., Ye F., Afshari A., Lai E., Wagner M., Chen J., and Weiner M.P. Flow cytometric platform for high-throughput single nucleotide polymorphism analysis. Biotechniques 30 (2001) 661-669
63. Touil T., Fitzgerald D., Zhang G.X., Rostami A., and Gran B. Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta. J. Immunol. 177 (2006) 7505-7509
64. Urcelay E., Blanco-Kelly F., de Las Heras V., de la Concha E.G., Arroyo R., and Martinez A. TLR4 haplotypes in multiple sclerosis: a case-control study in the Spanish population. J. Neuroimmunol. 192 (2007) 215-218
65. Vella A., Cooper J.D., Lowe C.E., Walker N., Nutland S., Widmer B., Jones R., Ring S.M., McArdle W., Pembrey M.E., Strachan D.P., Dunger D.B., Twells R.C., Clayton D.G., and Todd J.A. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 76 (2005) 773-779
66. Ye F., Li M.S., Taylor J.D., Nguyen Q., Colton H.M., Casey W.M., Wagner M., Weiner M.P., and Chen J. Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification. Hum. Mutat. 17 (2001) 305-316
67. Zhao Z.F., Cui B., Chen H.Y., Wang S., Li I., Gu X.J., Qi L., Li X.Y., Ning G., and Zhao Y.J. The A946T polymorphism in the interferon induced helicase gene does not confer susceptibility to Graves' disease in Chinese population. Endocrine 32 (2007) 143-147